Literature DB >> 11756963

Low-dose low-molecular-weight heparin in lichen planus.

Ranju Rai, Inderjeet Kaur, Bhushan Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11756963     DOI： 10.1067/mjd.2002.117389

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

Review 1.  Update on lichen planus and its clinical variants.

Authors:  Gillian Weston; Michael Payette
Journal:  Int J Womens Dermatol       Date:  2015-09-16

Review 2.  Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.

Authors:  Rahul P Patel; Madhur D Shastri; Long Chiau Ming; Syed Tabish R Zaidi; Gregory M Peterson
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

3.  Orally Administered Enoxaparin Ameliorates Acute Colitis by Reducing Macrophage-Associated Inflammatory Responses.

Authors:  Qi Ying Lean; Rajaraman D Eri; Sarron Randall-Demllo; Sukhwinder Singh Sohal; Niall Stewart; Gregory M Peterson; Nuri Gueven; Rahul P Patel
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

4.  Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; A clinical trial.

Authors:  Fariba Iraji; Ali Asilian; Ahmad Saeidi; Amir Hossein Siadat; Ali Reza Saeidi; Akbar Hassanzadeh
Journal:  Adv Biomed Res       Date:  2013-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.